| Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice E Beli, Y Yan, L Moldovan, CP Vieira, R Gao, Y Duan, R Prasad, ... Diabetes 67 (9), 1867-1879, 2018 | 286 | 2018 |
| 68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact on salvage … J Calais, J Czernin, M Cao, AU Kishan, JV Hegde, N Shaverdian, ... Journal of Nuclear Medicine 59 (2), 230-237, 2018 | 267 | 2018 |
| Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ... JAMA network open 2 (2), e188006-e188006, 2019 | 260 | 2019 |
| Impact of 68Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence J Calais, WP Fendler, M Eiber, J Gartmann, FI Chu, NG Nickols, RE Reiter, ... Journal of Nuclear Medicine 59 (3), 434-441, 2018 | 152 | 2018 |
| Deep learning approaches using 2D and 3D convolutional neural networks for generating male pelvic synthetic computed tomography from magnetic resonance imaging J Fu, Y Yang, K Singhrao, D Ruan, FI Chu, DA Low, JH Lewis Medical physics 46 (9), 3788-3798, 2019 | 91 | 2019 |
| A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma A Kalbasi, M Kamrava, FI Chu, D Telesca, R Van Dams, Y Yang, D Ruan, ... Clinical Cancer Research 26 (8), 1829-1836, 2020 | 72 | 2020 |
| Local failure and survival after definitive radiotherapy for aggressive prostate cancer: an individual patient-level meta-analysis of six randomized trials AU Kishan, FI Chu, CR King, W Seiferheld, DE Spratt, P Tran, X Wang, ... European urology 77 (2), 201-208, 2020 | 43 | 2020 |
| Local failure events in prostate cancer treated with radiotherapy: a pooled analysis of 18 randomized trials from the meta-analysis of randomized trials in cancer of the … TM Ma, FI Chu, H Sandler, FY Feng, JA Efstathiou, CU Jones, ... European urology 82 (5), 487-498, 2022 | 35 | 2022 |
| Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial R van Dams, TC Wu, AU Kishan, AC Raldow, FI Chu, J Hernandez, ... Radiotherapy and Oncology 170, 14-20, 2022 | 30 | 2022 |
| Evaluation of sex distribution of industry payments among radiation oncologists JK Weng, LF Valle, GE Nam, FI Chu, ML Steinberg, AC Raldow JAMA network open 2 (1), e187377-e187377, 2019 | 30 | 2019 |
| Assessment of differences in clinical activity and Medicare payments among female and male radiation oncologists L Valle, J Weng, R Jagsi, FI Chu, S Ahmad, M Steinberg, A Raldow JAMA Network Open 2 (3), e190932-e190932, 2019 | 26 | 2019 |
| Improving wellbeing and reducing future world population WW Murdoch, FI Chu, A Stewart-Oaten, MQ Wilber PloS one 13 (9), e0202851, 2018 | 24 | 2018 |
| Multi-institutional analysis of prostate-specific antigen kinetics after stereotactic body radiation therapy NY Jiang, AT Dang, Y Yuan, FI Chu, D Shabsovich, CR King, SP Collins, ... International Journal of Radiation Oncology* Biology* Physics 105 (3), 628-636, 2019 | 23 | 2019 |
| Clinical outcomes of stereotactic magnetic resonance image‐guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis SM Yoon, E Luterstein, FI Chu, M Cao, J Lamb, N Agazaryan, D Low, ... Cancer medicine 10 (17), 5897-5906, 2021 | 21 | 2021 |
| Comparing outcomes of patients with early-stage non–small-cell lung cancer treated with stereotactic body radiotherapy based on frailty status G Raghavan, N Shaverdian, S Chan, FI Chu, P Lee Clinical Lung Cancer 19 (5), e759-e766, 2018 | 19 | 2018 |
| The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells NG Nickols, E Ganapathy, C Nguyen, N Kane, L Lin, S Diaz-Perez, ... Prostate cancer and prostatic diseases 24 (1), 135-139, 2021 | 16 | 2021 |
| Assessment of toxic effects associated with dose-fractionated radiotherapy among patients with cancer and comorbid collagen vascular disease SM Yoon, FI Chu, D Ruan, ML Steinberg, A Raldow, P Lee JAMA Network Open 4 (2), e2034074-e2034074, 2021 | 14 | 2021 |
| Impact of open access to physician notes on radiation oncology patients: results from an exploratory survey N Shaverdian, EM Chang, FI Chu, EG Morasso, MA Pfeffer, EM Cheng, ... Practical radiation oncology 9 (2), 102-107, 2019 | 12 | 2019 |
| Associations between structure and function are different in healthy and glaucomatous eyes FI Chu, I Marín-Franch, K Ramezani, L Racette PLoS One 13 (5), e0196814, 2018 | 12 | 2018 |
| Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer. JAMA Netw Open 2 (2): e188006 AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ... | 12 | 2018 |
